Inhibrx Biosciences

INBX · NASDAQ

$95.30+$5.51 (+6.14%)TodayMarket closed ·
Prev close $89.79

Who owns INBX

Largest institutional holders, from their latest 13F filings

Top institutional holders of INBX
HolderShares% of shares
Viking Global Investors LP7.15M48.74%
RA Capital Management, LP4.72M32.20%
Perceptive Advisors LLC4.26M29.01%
Kayyem (Jon Faiz)3.27M22.32%
Lappe Mark3.05M20.76%
BlackRock Institutional Trust Company, N.A.2.47M16.85%
Eckelman (Brendan P)2.36M16.06%
Woodline Partners LP2.32M15.80%
The Vanguard Group, Inc.1.87M12.75%
TCG Crossover Management, LLC1.75M11.93%

Largest mutual fund holders

Top mutual fund holders of INBX
HolderShares% of shares
SPDR S&P Biotech ETF1.68M11.47%
Vanguard Total Stock Market Index Fund1.12M7.65%
iShares Russell 2000 ETF836.68K5.70%
Vanguard Extended Market Index Fund394.17K2.69%
Fidelity Small Cap Index Fund346.98K2.37%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $6.35M (20 trades) and sold $279.01K (5 trades) of INBX on the open market.

Latest INBX insider transactions
InsiderTypeSharesValue
Lappe MarkBuy100$8.58K
Lappe MarkBuy2.45K$208.33K
Lappe MarkBuy2.45K$205.89K
Lappe MarkBuy100$8.58K
Lappe MarkBuy2.47K$209.95K
Lappe MarkBuy2.47K$207.65K
Lappe MarkBuy3.00K$305.11K
Lappe MarkBuy1.50K$148.32K
Lappe MarkBuy2.18K$216.73K
Lappe MarkBuy3.32K$328.63K

Short interest

Settled Sep 30, 2026

Shares short
3.43M
Days to cover
11.82
% of shares outstanding
23.40%
Average daily volume
290.36K
Change since last report
+1.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.